Pharmaceutical Executive
June 25, 2010
Features
0
0
Strong, skilled management is on the agenda as never before. Find out who made 2010's roster of high-potential change masters-and how they plan to lead the industry through the turbulent times ahead.
June 01, 2010
Issue PDF
0
0
Emerging Pharma Leaders
June 01, 2010
Back Page
0
0
The public-interest charity takes on pharma-influenced medicing and drug-resistant bacteria.
June 01, 2010
Columns
0
0
Social networking helps sponsors drive clinical trials recruitment.
June 01, 2010
Features
0
0
Lewis Morris, top lawyer in HHS's office of inspector general, explains his new move to target pharma execs for serious and ongoing healthcare fraud.
June 01, 2010
Columns
0
0
Improving communication means appealing to physicians' heads as well as their hearts.
June 01, 2010
Columns
0
0
Pharma companies can maximize partnership benefits with social media.
June 01, 2010
Washington Report
0
0
FDA and industry seek to ensure drug quality in a world complicated by global outsourcing and theft.
June 01, 2010
From the Editor
0
0
Innovation in industry has always required a strong internal champion; the danger is a process led by the risk-adverse and externally-driven stakeholder consensus called "death by faint praise." Is this really what we mean by "bold partnerships?"